Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
---|
03/23/2000 | WO2000015992A2 Tube for lining pipes and channels, and a method and device for the production thereof |
03/23/2000 | DE19850645C1 Single stage recovery of high purity isoquinoline, useful e.g. as starting material for drugs or dyes, by crystallizing isoquinoline fraction from coal-tar having restricted quinoline and quinaldine contents |
03/23/2000 | CA2343111A1 Tube for lining pipes and channels, and a method and device for the production thereof |
03/22/2000 | EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction |
03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
03/21/2000 | US6040314 Bicyclic isothiourea derivatives useful in therapy |
03/16/2000 | WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
03/16/2000 | WO1999067218A3 Method of preparing 5- or 8-bromoisoquinoline derivatives |
03/16/2000 | WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders |
03/16/2000 | CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
03/15/2000 | EP0984967A1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
03/15/2000 | EP0984778A1 Neuropeptide-y ligands |
03/15/2000 | CN1247561A Color-safe bleach boosters, compsns. and laundry methods employing same |
03/14/2000 | US6037157 Method for improving pharmacokinetics |
03/08/2000 | EP0983999A1 Process for producing amide derivatives and intermediates |
03/08/2000 | EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds |
03/08/2000 | EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
03/08/2000 | EP0983245A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
03/08/2000 | EP0983244A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
03/07/2000 | US6034104 Anticoagulant agents |
03/07/2000 | US6034098 Inhibitors of microsomal triglyceride transfer protein and method |
03/07/2000 | US6034097 Isoquinolines useful as analgesics |
03/07/2000 | US6034096 Compounds with anti-inflammatory and immunosuppressive activities |
03/07/2000 | US6034095 Rheumatic diseases; osteoporosis |
03/07/2000 | US6034094 Pharmaceutically useful 3,4-dihydroisoquinoline |
03/01/2000 | EP0981517A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
03/01/2000 | EP0981516A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d?3 receptors |
03/01/2000 | CN1049891C Dicyclomine compound and preparing method, and drug composition containing said compound |
02/29/2000 | US6031130 Catalyzing the dehydration of a secondary amine compound by adding a rhenium catalyst and aqueous hydrogen peroxide to a mixture also containing a dehydrating agent; use as photographic developers, additives for polymers |
02/29/2000 | US6031097 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
02/24/2000 | WO2000009486A1 Substituted isoquinoline derivatives and their use as anticonvulsivants |
02/24/2000 | CA2340092A1 Substituted isoquinoline derivatives and their use as anticonvulsivants |
02/23/2000 | EP0980358A1 Pharmacological agents |
02/23/2000 | EP0980357A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors |
02/22/2000 | CA2050352C Substituted 2-propenyl derivatives of nitrogen heterocycles |
02/17/2000 | WO2000007993A1 Substituted isoquinoleines and their use as anticonvulsivants |
02/17/2000 | WO1999060985A3 Compounds, compositions and methods for treating erectile dysfunction |
02/15/2000 | US6025493 For treatment of psychological disorders, alzheimer's disease, parkinson's disease, nervous system disorders |
02/09/2000 | EP0977815A1 ALKYL, ALKENYL AND ALKYNYL CHRYSAMINE G DERIVATIVES FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND $i(IN VIVO) IMAGING AND PREVENTION OF AMYLOID DEPOSITION |
02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
02/06/2000 | CA2279747A1 Estrogen agonists/antagonists |
02/03/2000 | WO2000005214A2 Isoquinolines as urokinase inhibitors |
02/03/2000 | WO2000005210A1 N,n-substituted cyclic amine derivatives |
02/03/2000 | WO2000005184A1 Method for hydrogenating unsaturated heterocyclic compounds |
02/03/2000 | WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
02/03/2000 | WO1999065922A3 Prenyl transferase inhibitors |
02/03/2000 | WO1998050365A9 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
02/03/2000 | CA2337941A1 N,n-substituted cyclic amine compounds |
02/03/2000 | CA2337247A1 Isquinolines as urokinase inhibitors |
02/03/2000 | CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
02/02/2000 | EP0976732A1 1,4-substituted cyclic amine derivatives |
02/02/2000 | EP0975614A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity |
02/02/2000 | EP0975601A1 Process for making a butylthio-isoquinoline and intermediates therefor |
02/02/2000 | EP0975600A1 Heterocyclic derivatives and their use as antithrombotic agents |
02/02/2000 | EP0975599A1 Subtituted isoquinolines as ultra short acting neuromuscular blockers |
02/02/2000 | EP0975598A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide |
02/02/2000 | EP0975353A1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
02/02/2000 | CN1243510A Tricyclicbenzo [3] isoindole and benzo (h) isoquinoline |
02/01/2000 | US6020362 Glycoprotein IIB IIIA antagonists |
02/01/2000 | US6020358 Substituted phenethylsulfones and method of reducing TNFα levels |
01/27/2000 | DE19832810A1 Hydrogenation of unsaturated heterocyclic compounds, especially pyridine compounds, uses a catalyst containing a Subgroup VIII metal on a macroporous support |
01/26/2000 | EP0973778A1 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE |
01/26/2000 | EP0973396A1 A method of treating cancer |
01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
01/25/2000 | US6018048 Noble metal Raney catalysts and preparation of hydrogenated compounds therewith |
01/20/2000 | WO2000002862A1 Retroviral protease inhibitors |
01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
01/19/2000 | EP0971898A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
01/19/2000 | EP0971897A1 Anti-convulsant isoquinolyl-benzamide derivatives |
01/18/2000 | US6015903 Method of resolving racemic mixtures |
01/18/2000 | US6015901 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
01/18/2000 | US6015900 N-aminoalkylfluorenecarboxamides |
01/13/2000 | WO2000001376A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
01/13/2000 | WO1999018941A3 Ih-MODULATORS |
01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
01/12/2000 | EP0970055A2 Hiv protease inhibitors |
01/12/2000 | EP0970054A1 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands |
01/12/2000 | EP0808307B1 Bicyclic isothiourea derivatives useful in therapy |
01/12/2000 | CN1241181A Pharmaceutical compounds |
01/11/2000 | CA2195027C Hiv protease inhibitors useful for the treatment of aids |
01/06/2000 | WO2000000494A1 Preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxyamide |
01/06/2000 | WO2000000491A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents |
01/06/2000 | WO2000000472A1 5-ht7 receptor antagonists |
01/06/2000 | CA2335595A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents |
01/05/2000 | EP0968199A1 Antibacterial heterocyclic amino acid derivatives |
01/05/2000 | EP0968190A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
01/05/2000 | EP0968179A1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
01/04/2000 | US6011175 Inhibition of farnesyltransferase |
01/04/2000 | US6011150 Synthetic intermediate of a 1 beta-methylcarbapenem derivative |
01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
12/29/1999 | WO1999067218A2 Method of preparing 5- or 8-bromoisoquinoline derivatives |
12/29/1999 | EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
12/29/1999 | EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
12/29/1999 | EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
12/28/1999 | US6008367 Intermediate for synthesis of anticoagulant agents |
12/28/1999 | US6008352 1-(isoquinolin-1-yl)-4-(1-phenylmethyl) piperazines; dopamine receptor subtype specific ligands |
12/23/1999 | WO1999065922A2 Prenyl transferase inhibitors |
12/23/1999 | CA2337603A1 Prenyl transferase inhibitors |